OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 37
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains
Kewen Peng, Shamar D. Wallace, Saket R. Bagde, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 5, pp. 1093-1105
Open Access | Times Cited: 1
Kewen Peng, Shamar D. Wallace, Saket R. Bagde, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 5, pp. 1093-1105
Open Access | Times Cited: 1
Discovery of 2-amide-3-methylester thiophenes that target SARS-CoV-2 Mac1 and repress coronavirus replication, validating Mac1 as an anti-viral target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis
Li Wang, María Adelina Schlie Guzmán, Diego Muñoz‐Santos, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 3
Li Wang, María Adelina Schlie Guzmán, Diego Muñoz‐Santos, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 3
Multiple layers of innate immune response antagonism of SARS-CoV-2
Fuchun Zhou, Sivakumar Periasamy, Nathaniel D. Jackson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Fuchun Zhou, Sivakumar Periasamy, Nathaniel D. Jackson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
PARP1 as an Epigenetic Modulator: Implications for the Regulation of Host-Viral Dynamics
Asher A. Sobotka, Italo Tempera
Pathogens (2024) Vol. 13, Iss. 2, pp. 131-131
Open Access
Asher A. Sobotka, Italo Tempera
Pathogens (2024) Vol. 13, Iss. 2, pp. 131-131
Open Access
HTRF-based assay for detection of mono-ADP-ribosyl hydrolyzing macrodomains and inhibitor screening
Niklas Ildefeld, Dieter Steinhilber, Ewgenij Proschak, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110333-110333
Open Access
Niklas Ildefeld, Dieter Steinhilber, Ewgenij Proschak, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110333-110333
Open Access
Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1
Koen J. Rijpkema, M. Schuller, Miriam S. van der Veer, et al.
Organic Letters (2024) Vol. 26, Iss. 27, pp. 5700-5704
Open Access
Koen J. Rijpkema, M. Schuller, Miriam S. van der Veer, et al.
Organic Letters (2024) Vol. 26, Iss. 27, pp. 5700-5704
Open Access
PARP14 mediated SQSTM1/p62 cysteine ADP-ribosylation is counteracted by the SARS-CoV-2 macrodomain
David Kubon, Deena M. Leslie Pedrioli, Michael O. Hottiger
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
David Kubon, Deena M. Leslie Pedrioli, Michael O. Hottiger
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication
Jessica J. Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
(2024)
Open Access
Jessica J. Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
(2024)
Open Access
Human coronaviruses: activation and antagonism of innate immune responses
Nikhila S. Tanneti, Helen A. Stillwell, Susan R. Weiss
Microbiology and Molecular Biology Reviews (2024)
Closed Access
Nikhila S. Tanneti, Helen A. Stillwell, Susan R. Weiss
Microbiology and Molecular Biology Reviews (2024)
Closed Access
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesisin vivo
Taha Y. Taha, Rahul K. Suryawanshi, Irene P. Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Taha Y. Taha, Rahul K. Suryawanshi, Irene P. Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell and tissue specific manner
Catherine M. Kerr, Srivatsan Parthasarathy, Nancy Schwarting, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Catherine M. Kerr, Srivatsan Parthasarathy, Nancy Schwarting, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
